As well, GPC3-CAR-iPSC-NK cells could produce higher levels of IFN-γ against GPC3-expressing tumor cells in vitro, and also stimulated substantial therapeutic effect in OC murine models, as supported by prolonged survival of these models compared with the control group. This evidence concerns the gene IFNG and neoplasm.